ホーム › 急性骨髄性白血病 › テネシー › Memphis
Memphis、TNにおける急性骨髄性白血病の臨床試験
Memphisとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12マイル先
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23マイル先
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
被験者募集中第1相
- Saint Jude Children's Research Hospital, Memphis
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12マイル先
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23マイル先
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12マイル先
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23マイル先
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12マイル先
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23マイル先
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
被験者募集中第2相
- St. Jude Children's Research Hospital, Memphis
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
被験者募集中第1相
- St. Jude Children's Research Hospital, Memphis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Saint Jude Children's Research Hospital, Memphis
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- St. Jude Children's Research Hospital, Memphis
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
被験者募集中第3相
- Baptist Clinical Research Institute, Memphis
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
被験者募集中第1相
- Baptist Health Care Corporation, Memphis
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
被験者募集中第1相
- St. Jude Children's Research Hospital, Memphis
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- St. Jude Childrens Research Hospital, Memphis
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
被験者募集中第1相
- St. Jude Children's Research Hospital, Memphis
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
被験者募集中第1相
- St. Jude Children's Research Hospital, Memphis
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Seattle, WA41件の研究
- Baldwin Park, CA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA31件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Memphisにおける他の研究
- がん（全種類）31件の研究
- 非小細胞肺癌23件の研究
- 乳がん22件の研究
- 肺がん18件の研究
- 鎌状赤血球症18件の研究
- 急性リンパ性白血病16件の研究
- 心不全13件の研究
- 軟部組織肉腫11件の研究
- 悪性黒色腫11件の研究
- 前立腺がん11件の研究
- 大腸癌11件の研究
- 骨肉腫10件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。